See also
ˇ Show More
The income statement presents information on the financial results of a company's business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.
You have visited 10 password protected pages for free. Others contain data covered by
.
Sign Up Now to get full access to whole website and cut out all advertisements.
Abbott Laboratories, Consolidated Income Statement
USD $ in thousands

| 12 months ended | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2007 | |
|---|---|---|---|---|---|---|
![]() |
Net sales | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Cost of products sold | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Gross profit | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Research and development | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Acquired in-process and collaborations research and development | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Selling, general and administrative | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Operating earnings | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Interest expense | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Interest income | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Income from the TAP Pharmaceutical Products Inc. joint venture | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Net foreign exchange gain (loss) | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Other income (expense), net | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Earnings from continuing operations before taxes | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Taxes on earnings | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Earnings from continuing operations | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Gain on sale of discontinued operations, net of taxes | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Net earnings | ![]() |
![]() |
![]() |
![]() |
![]() |
| Item | Description | The company |
|---|---|---|
| Net sales | Aggregate revenue recognized during the period (derived from goods sold, services rendered, insurance premiums, or other activities that constitute an entity's earning process). For financial services companies, also includes investment and interest income, and sales and trading gains. | Abbott Laboratories's net sales increased from 2009 to 2010 and from 2010 to 2011. |
| Operating earnings | The net result for the period of deducting operating expenses from operating revenues. | Abbott Laboratories's operating earnings declined from 2009 to 2010 and from 2010 to 2011. |
| Earnings from continuing operations before taxes | Sum of operating profit and nonoperating income (expense) before income (loss) from equity method investments, income taxes, extraordinary items, cumulative effects of changes in accounting principles, and noncontrolling interest. | Abbott Laboratories's earnings from continuing operations before taxes declined from 2009 to 2010 and from 2010 to 2011. |
| Earnings from continuing operations | This represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses and taxes from ongoing operations before extraordinary items, cumulative effects of changes in accounting principles, and noncontrolling interest. | Abbott Laboratories's earnings from continuing operations declined from 2009 to 2010 but then slightly increased from 2010 to 2011. |
| Net earnings | The portion of consolidated profit or loss for the period, net of income taxes, which is attributable to the parent. If the entity does not present consolidated financial statements, the amount of profit or loss for the period, net of income taxes. | Abbott Laboratories's net earnings declined from 2009 to 2010 but then slightly increased from 2010 to 2011. |
Stock Analysis on Net (www.stock-analysis-on.net)
Copyright © 2012 EBIT Financial Analyses Center